A video shows engineered heart muscle made up of allogeneic induced pluripotent stem-cell–derived cardiomyocytes and stromal cells for cardiac remuscularization in patients with heart failure. Read the full BioVAT-HF study results to learn more: nej.md/4nQ3Knc

Stem-Cell–Derived Biologic Ventricular Assist Tissue in Heart Failure | New England Journal of Medicine 👍👍👍 @dzhk_germany @pharmaumg @tim_friede nejm.org/doi/full/10.1056/NE…

Original Article: Left Atrial Appendage Closure or Medical Therapy in Atrial Fibrillation (CLOSURE-AF trial) nejm.org/doi/full/10.1056/NE… Editorial: Left Atrial Appendage Closure — Another Overused Method in Cardiology? nejm.org/doi/full/10.1056/NE… #Cardiology

Among patients with atrial fibrillation at high risk for stroke and bleeding, left atrial appendage closure was not noninferior to medical therapy in reducing the risk of stroke, embolism, major bleeding, or death at 3 years. Full CLOSURE-AF trial results: nejm.org/doi/full/10.1056/NE… Editorial: Left Atrial Appendage Closure — Another Overused Method in Cardiology? nejm.org/doi/full/10.1056/NE…

MINI SYMPOSIUM "Adaptive Designs: Modern Approaches in Clinical Research" with Cyrus Mehta (President and Co-founder of @Cytel ; @HarvardChanSPH) and Frank Konietschke (@ChariteBerlin) at Göttingen (Germany) on Friday 27 FEB 2026. medstat.umg.eu/veranstaltung…

Prof. Frank Harrell, a leading figure in Bayesian biostatistics and experienced FDA advisor, joins Dr. Scott Berry on "In the Interim…" for an unfiltered assessment of statistical barriers and regulatory realities shaping clinical trial design. Prof. Harrell addresses the slow adoption of Bayesian approaches within the clinical trial community, critical flaws in type 1 error fixation, and the value of longitudinal and ordinal outcome modeling. Harrell describes both the influence of Dr. Don Berry and the ongoing effort to guide U.S. regulatory frameworks. Listen to this fascinating conversation today to learn more about the Bayesian approach to clinical trials: berryconsultants.com/resourc…

🚀 Big news: IBS has a new look online! 🌐 Modern homepage 🎨 Fresh branding 🧭 Easier navigation 👥 Same great community Check out the refreshed IBS website today → biometricsociety.org/home

🏆 IBS is now accepting nominations for three major awards: Honorary Life Membership, the Rob Kempton Award, and the Award for Outstanding Contribution to IBS. Submit by 31 Oct 2025. Winners honored at #IBC2026 in Seoul. members.biometricsociety.org…

*NEW COURSE* "Individual Participant Data (IPD) Meta-Analysis Projects: A Practical Introduction" 📅 23-24 Sept 2025 | Online For all researchers considering or embarking on IPDMA projects tinyurl.com/3y7phy86

Science on Friday: How Real-World Evidence Can Complement Randomized Clinial Trials In Cardiovascular Medicine - Register for free - organized by ⁦@dzhk_germany⁩ 10/10/25 - 5-6pm online via Zoom dzhk.de/en/newsroom/events/c…

📢 Call for Abstracts is OPEN! Present your research at IBC2026 in Seoul | 12–16 July 2026. Contributed oral & poster sessions welcome across statistics, data science & biosciences. 🗓 Submit by 3 Nov 2025 🔗members.biometricsociety.org…

Random-effects meta-analyis of a single study? Yes, this makes sense e.g. when deriving a meta-analytic predictive (MAP) prior for the analysis of another study. In this setting there are close links to power priors and bias allowance models. arxiv.org/abs/2505.15502

What a fantastic success 😀🍀👏 'Cardio Pulmonary Institute' for the 4th time in a row awarded 'Excellence Cluster' status by the #DFG #Exzellenzwettbewerb Thanks to all wonderful scientists contributing over 19 years 🫶 @dzhk_germany @StefanieDimmel1 @CPI_ExStra @ERC_Research

💙 Interested in ESCAPE Videos? Check out our video playlist, where we break down key aspects of the project, from our innovative Blended Collaborative Care (BCC) approach to the role of care managers and digital health technologies. 📺 Watch here: bit.ly/3Edl2sa

🎉 Major Milestone for ESCAPE! 🎉 ESCAPE has officially reached its recruitment target of 300 patients in our randomised trial! Now, our focus shifts to evaluation and implementation, with care managers leading the intervention phase. 🔍 Read more here: bit.ly/3FZwQyQ

#DGKJahrestagung: Frisch aus dem Vortrag – hier finden Sie die zentrale Zusammenfassung in unserer Summary Card! "Transition from Asymptomatic Systolic Chronic Heart Failure (TRANSITIONCHF)" Sprecher: A. Sandek Diskutant: R. Pfister #DGK2025JT #Kardiologie #KardiovaskuläreMedizin

Zusammen mit der @AGIKinterv haben wir ein Simulationskonzept für die Jahrestagung auf die Beine gestellt. Es dürfen alle Kommen und Katheterinterventionelle Verfahren selbst probieren. @YoungDgk @YoungDZHK @dzhk_germany @DGK_org

Proud to be part of this huge effort to synthesize the trial data with IV iron in HF with ID nature.com/articles/s41591-0…